Octapharma Data Breach Investigation

Turke & Strauss LLP, a leading data breach law firm, is investigating Octapharma Plasma (“Octapharma”) regarding its recent cybersecurity incident. The Octapharma cybersecurity incident may have impacted the privacy of sensitive personal information belonging to an undetermined number of individuals.


Octapharma is a global healthcare and pharmaceutical company based in Switzerland. Founded in 1983, Octapharma is one of the largest human protein product manufacturers in the world, developing and producing medicines based on human proteins from human cell lines and human plasma, sourced from its own plasma donation centers and other external sources.2 Today, Octapharma supports the treatment of patients in 118 countries with products across three therapeutic areas: immunotherapy, hematology, and critical care.3 Headquartered in Lachen, Switzerland, Octapharma employs over 11,000 individuals across seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 195 plasma donation centers throughout Europe and the US.3


On April 19, 2024, Octapharma reported that it had experienced a cybersecurity incident impacting the functionality of its systems. According to a statement made on its website, “On Wednesday, April 17, Octapharma Plasma USA detected suspicious activity on its network. We activated our incident response processes to investigate and also took systems offline to limit the potential scope of this event. Our staff are working tirelessly to reopen our USA plasma donation centers as soon as possible.”1 As of April 24, 2024, Octapharma has not disclosed the specific nature of the cybersecurity incident and whether the incident resulted in a data breach.

If you believe that you have been impacted by the Octapharma Plasma cybersecurity incident:

We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at (608) 237-1775 or sam@turkestrauss.com.

If you were impacted by the Octapharma cybersecurity incident, you may consider taking the following steps to protect your personal information.

  1. Carefully review the breach notice and retain a copy;
  2. Enroll in any free credit monitoring services that may be provided by Octapharma Plasma;
  3. Change passwords and security questions for online accounts;
  4. Regularly review account statements for signs of fraud or unauthorized activity;
  5. Monitor credit reports for signs of identity theft; and
  6. Contact a credit bureau(s) to request a temporary fraud alert.

Share This Post: